Deadline Looms for ARDX Investors: Legal Firm Investigates Possible Claims
Sep 8, 2024
ARDX Equities
Ardelyx Unveils Additional Clinical Data for IBSRELA® at Digestive Disease Week 2024
May 21, 2024
Ardelyx Showcases Further Evidence of IBSRELA® Efficacy at 2024 Digestive Disease Week
May 21, 2024
Ardelyx Sets Date for Update on IBSRELA® and IBS-C Sector Expert Discussion
Jan 4, 2024
Ardelyx Announces Upcoming Update on IBSRELA® and Expert Discussion on IBS-C Market
Jan 3, 2024